Grants Awarded

The number of grants awarded by the Histiocytosis Association varies each year. It is determined by a variety of factors including, but not limited to, the quality of eligible applications received and the availability of funds.

Use the filters below to see information for all of the research projects the Association has funded since 1992.

To filter by year and disease type, select the year first.

All
  • All
  • HLH/FEL/FHL
  • LCH
  • Rare Histiocytic Disorders and Other Topics

The mechanisms of cytotoxic granule exocytosis underlying hemophagocytic lymphohistiocytosis

Principal Investigator Shuzo Sugita University Health Network Toronto, ON Canada Date of Award December 2018 Amount of Award…

Read More

Maintenance of the IT platform of the LCH-IV Treatment Protocol Study (LCH-IVTPS)

Principal Investigator Milen Minkov CCRI, St. Anna Kinderkrebsforschung Vienna, Austria Date of Award December 2017 Amount of…

Read More

A Study of Advanced Neuroimaging and Cognition in Adults with Histiocytic Disorders

Principal Investigator Eli Diamond, M.D. Memorial Sloan Kettering Cancer Center New York, NY USA Date of Award…

Read More

The use of a newly generated murine model to determine the broad role of STXBP2 in FHL5 pathogenesis

Principal Investigator Fernando Sepulveda, Ph.D. Imagine Institute Paris, France Date of Award December 2016 Amount of Award…

Read More

HIF-1α Signaling is a Central Pathobiologic Mediator of Hemophagocytic Lymphohistiocytosis

Principal Investigator Gang Huang, Ph.D. Children’s Hospital Medical Center Cincinnati, OH USA Date of Award December 2016…

Read More

Genetic Defects in Cytolysis in Patients with Macrophage Activation Syndrome Enrolled in a Clinical Trial to Explore Interleukin-1 Blockage Therapy

Principal Investigator Randy Cron, M.D., Ph.D. University of Alabama at Birmingham Birmingham, AL USA Date of Award…

Read More

Innate T cells in Langerhan’s Cell Histiocytosis

Principal Investigator Stuart Berzins, Ph.D. Federation University Australia Ballarat, Victoria, Australia Date of Award December 2016 Amount…

Read More

MEK Inhibition in the Therapy of Histiocytic Neoplasms

Principal Investigator Omar Abdel-Wahab, MD Memorial Sloan Kettering Cancer Center New York, New York USA Date of…

Read More

Identification of Molecular Mechanisms Underlying Defective Cytotoxic Lymphocyte Function in Chediak-Higashi Syndrome, a Histiocytic Lysosomal Storage Disorder with Immunodeficiency

Principal Investigator Konrad Krzewski, PhD National Institute of Allergy and Infectious Diseases, National Institutes of Health Rockville,…

Read More